Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (181-190 of 325) with videos related to

Pageof 33
Sort By:
The Pediatric Infectious Disease Journal|February 14, 2017
Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South AfricaLynn Ramirez-Avila, Susan Regan, Christie Cloete, et al.
AIDS (London, England)|July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
JAMA Health Forum|May 10, 2024
Projected Life Expectancy for Adolescents With HIV in the USAnne M Neilan, Ogochukwu L Ufio, Isaac Ravi Brenner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Cost of an HIV Medical Care Coordination Program in Los Angeles CountyBruce R Schackman, Philip J Jeng, Moses J E Flash, et al.
The American Journal of Medicine|December 6, 2003
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infectionSue J Goldie, A David Paltiel, Milton C Weinstein, et al.
Plos One|May 5, 2012
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysisMai T Pho, Soumya Swaminathan, Nagalingeswaran Kumarasamy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessApril D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
AIDS (London, England)|February 16, 2012
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysisJason R Andrews, Stephen D Lawn, Corina Rusu, et al.
AIDS and Behavior|April 16, 2015
Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South AfricaIngrid V Bassett, Susan Regan, Hlengiwe Mbonambi, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Pageof 33

Showing results (181-190 of 325) with videos related to

Sort By:
Pageof 33
The Pediatric Infectious Disease Journal|February 14, 2017
Adolescent Linkage to Care After a Large-scale Transfer From a Hospital-based HIV Clinic to the Public Sector in South AfricaLynn Ramirez-Avila, Susan Regan, Christie Cloete, et al.
AIDS (London, England)|July 30, 2005
Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysisYazdan Yazdanpanah, Elena Losina, Xavier Anglaret, et al.
JAMA Health Forum|May 10, 2024
Projected Life Expectancy for Adolescents With HIV in the USAnne M Neilan, Ogochukwu L Ufio, Isaac Ravi Brenner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2019
Cost of an HIV Medical Care Coordination Program in Los Angeles CountyBruce R Schackman, Philip J Jeng, Moses J E Flash, et al.
The American Journal of Medicine|December 6, 2003
Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infectionSue J Goldie, A David Paltiel, Milton C Weinstein, et al.
Plos One|May 5, 2012
The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysisMai T Pho, Soumya Swaminathan, Nagalingeswaran Kumarasamy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2010
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessApril D Kimmel, Milton C Weinstein, Xavier Anglaret, et al.
AIDS (London, England)|February 16, 2012
The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysisJason R Andrews, Stephen D Lawn, Corina Rusu, et al.
AIDS and Behavior|April 16, 2015
Finding HIV in hard to reach populations: mobile HIV testing and geospatial mapping in Umlazi township, Durban, South AfricaIngrid V Bassett, Susan Regan, Hlengiwe Mbonambi, et al.
AIDS (London, England)|March 9, 2012
Projecting the clinical benefits and risks of using efavirenz-containing antiretroviral therapy regimens in women of childbearing ageEric N Ouattara, Xavier Anglaret, Angela Y Wong, et al.
Pageof 33